Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited ( (AU:FRE) ) has issued an update.
Firebrick Pharma Limited has issued 1,000,000 unlisted options exercisable at $0.15 and expiring on 10 February 2030. The options, which form part of previously announced transactions and are not intended to be quoted on the ASX, represent a further step in the company’s use of equity-based instruments to support its capital structure and align stakeholder incentives.
The issuance of these long-dated options may provide additional flexibility in future funding while limiting immediate dilution for existing shareholders. By opting for unquoted options, Firebrick can structure targeted incentives or commitments without impacting the liquidity profile of its quoted securities on the main market.
The most recent analyst rating on (AU:FRE) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Firebrick Pharma Limited stock, see the AU:FRE Stock Forecast page.
More about Firebrick Pharma Limited
Firebrick Pharma Limited is an Australian-listed pharmaceutical company focused on developing and commercialising healthcare products. The company’s activities centre on creating medically oriented offerings, with its securities traded on the ASX under the code FRE.
Average Trading Volume: 97,596
Technical Sentiment Signal: Hold
Current Market Cap: A$17.11M
For an in-depth examination of FRE stock, go to TipRanks’ Overview page.